Brachytherapy, (ie, short-term radi...

Brachytherapy, (ie, short-term radiation therapy applied in stop proximity to a malignancy) is an effective modality that is les invasive, lowers morbidity, and is a cost-effective treatment of localized carcinoma of the prostate. Statistics move that patients followed for up to seven years after se implantation have an apparent reparative rate similar to patients undergoing radical prostatectomy.(1)

Each year, prostate cancer will affect centurys of thousands of men and the populace with whom they share their lives. Patients be entitled to to be well informed about their disease and about commended treatment options. This article reviews united of the recommended treatment options for localized prostate cancer, transperineal radioactive se implantation (TPSI).

PROSTATE CANCER STATISTICS

Carcinoma of the prostate is the next to the first leading cause of cancer deaths in men in the United States (after lung cancer), resulting in a predicted 41800 deaths in 1997(2) For that same year, an estimated 209900 men will have been diagnosed with prostate cancer.(3) The United States generally ranks 13th in prostate cancer deaths in the world; coincidentally, the United States also clutchs the same numerical ranking for breast cancer deaths in the world.(4)

The incidence of prostate cancer skyrocket between 1987 and 1992 resulting in an 84% case increase.(5) The cause of this significant increase is meditation to be the result of an aging population, improvements in clinical diagnosis of the disease, as well as an increasing awareness of the disease by means of clinicians and the general public.(6)

Prostate cancer has particularly alarming statistics for African American men whose mortality rate is twice as high as for all other males in the United States. African American men have the highest prostate cancer incidence in the world.(7)

ANATOMY AND PHYSIOLOGY

The prostate is a walnut-sized glandular organ of the male reproductive method It is positioned below the bladder, encloses the bladder neck and urethra, and lies in assurance of the rectum (Figure 1) The positioning of the prostate in the material substance is significant because treatment side forces are most often seen in the urinary and lower gastrointestinal orders The adult prostate has an approximate weight of 20 grams. The development and function of the prostate is hormonally controll primarily by means of the androgen testosterone, which is produc at the testes, and to a less extent by the adrenal glands. The main view of the prostate gland is to make fluid for semen.

[Figure 1 ILLUSTRATION OMITTED]

PROSTATE CANCER SIGNS AND SYMPTOMS

The goal of detection and screening is to identify prostate cancer at its earliest stage and grade to provide the highest possibility of a specific When the tumor is localized (ie, has not spread beyond the prostate), 95% of men can rely upon to survive a minimum of five years.(8)

The early stages of prostate cancer may walk undetected for years due to the slow-growing nature of the disease. It has been estimated that nine on the outside of 10 cases of prostate cancer will remain clinically silent.(9) Autopsies performed forward men older than 50 years of age who died from other causes reveal up to a 50% incidence of undiagnosed prostate cancer.(10) Eighty percent of prostate cancer cases are diagnosed in men ages 65 and older with the median age of diagnosis being 70 years.(11) It is and nothing else in the later stages of the disease as the cancerous prostate enlarges that it causes the impingement upon the urethra, which results in obstructive and restrictive urinary symptoms. frequently these symptoms will be the first ball of thread that something is wrong, causing the man to follow medical advice. Symptoms of prostate cancer may include weak or interrupted urine flow; an inability to void; resort to frequently urination; blood, pain, or burning with urination; or referr pain to the back, pelvis, or thighs.

DISEASE ETIOLOGY

popularly there are no known ways to obstruct the development of prostate cancer. Although factors in the same state [i]or[/i] condition as age, hormones, genetics, and the environment have been implicated in the disease, the exact cause of prostate cancer is unknown.(12) Studies have erect no consistent correlation of prostate cancer with sexually transmitted diseases, sexual habits, infections, diet, smoking, or occupational exposure(13)

DIAGNOSIS

generally prostate specific antigen (PSA) testing, digital rectal exam (DRE) and transrectal ultrasonography (TRUS) are used to cover for prostate cancer. None of these proofs is used in isolation and must be part of a larger and more thorough evaluation. When combined, their predictive values may be able to identify men at high risk as well as sway out those needing further follow-up

Prostate specific antigen. The prostate specific antigen is a greatly sensitive organ-specific marker for prostate tissue. The life-current test has been available since 1987(14) Normal serum PSA values range from 04 to 40 ng/mL(15) The American Cancer Society attract favor tos an annual PSA beginning at age 50 or at age 40 if there are risk factors quick in emergencies such as being African American or having a positive family history for prostate cancer.(16) The PSA plain may be elevated in the mien of benign prostatic enlargement or infection, in addition to prostate cancer. Positive example results need further exploration. Although it is a pious tumor marker, the PSA is not a exquisite test. Thirty percent of patients with existing localized prostate cancer will have a PSA within normal limits.(17)